mitoxantrone,pegaspargase
servier,cspc pharmaceuticals
['pegaspargase', 'plm60']
congress #esmo22 | yunhong huang at guizhou medical university presented results from phase i/ii trial of plm60+pegaspargase in pts with extranodal nk/t-cell lymphoma. n=22 (treatment-na ve pts), cr: 68.2%, orr: 90.9%, median pfs: not reached, safety: manageable #lymsm #lymphoma 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm